Cleared Traditional

K802227 - ANASTIM II TRANSCUTANEOUS ELECTRICAL

K802227 is an FDA 510(k) clearance for ANASTIM II TRANSCUTANEOUS ELECTRICAL, manufactured by Biostim, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K802227 · Biostim, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1980
Decision
14d
Days
Class 2
Risk

K802227 is an FDA 510(k) clearance for the ANASTIM II TRANSCUTANEOUS ELECTRICAL. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Biostim, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 26, 1980 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biostim, Inc. devices

FDA 510(k) Submission Details - K802227

510(k) Number K802227 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 12, 1980
Decision Date September 26, 1980
Days to Decision 14 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
134d faster than avg
Panel avg: 148d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 287
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K802227.
NEUROPAC ULTRA I
K810593 · Medical Devices, Inc. · Mar 1981
TENSMATE EMPIMODEL 9980
K802507 · Empi · Dec 1980
SPEMBLY 9000 & 9300
K802063 · Spembly Medical , Ltd. · Oct 1980
EMPI MODEL 910S, TENS
K801112 · Empi · May 1980
TENZCARE DUAL-CHANNEL STIMULATOR
K800758 · 3M Company · Apr 1980
MODEL 980D TENS NEUROPACER
K792522 · Empi · Dec 1979